Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogression”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Testing effectiveness (Phase 2)Looking for participantsNCT07193641
What this trial is testing

A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Large-scale testing (Phase 3)Looking for participantsNCT06686771
What this trial is testing

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Canadian Cancer Trials Group 320
Testing effectiveness (Phase 2)Study completedNCT03696277
What this trial is testing

SAbR For Oligo-Progressive Renal Cell Cancer.

Who this might be right for
Oligoprogressive Renal Cell Carcinoma
University of Texas Southwestern Medical Center 21
Not applicableLooking for participantsNCT06101290
What this trial is testing

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Who this might be right for
Prostate CancerOligoprogressiveUrothelial Carcinoma+1 more
University of California, Davis 150
Not applicableLooking for participantsNCT06103669
What this trial is testing

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Who this might be right for
Breast CancerOligoprogressiveHead and Neck Cancer+2 more
University of California, Davis 250
Testing effectiveness (Phase 2)Looking for participantsNCT04974671
What this trial is testing

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressive+1 more
Yale University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05301881
What this trial is testing

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

Who this might be right for
Breast Cancer InvasiveMetastatic CancerOligoprogressive
The Netherlands Cancer Institute 56
Not applicableLooking for participantsNCT06103682
What this trial is testing

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Who this might be right for
Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung Cancer
University of California, Davis 100
Not applicableLooking for participantsNCT06918951
What this trial is testing

Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

Who this might be right for
OligoprogressionOligometastatic DiseaseOligoProgressive Metastatic Disease
British Columbia Cancer Agency 194
Testing effectiveness (Phase 2)Ended earlyNCT05846659
What this trial is testing

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies

Who this might be right for
Oligoprogressive
ImmuneSensor Therapeutics Inc. 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Not applicableLooking for participantsNCT07112170
What this trial is testing

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaOligoProgressive Metastatic Disease
University Health Network, Toronto 52
Large-scale testing (Phase 3)UnknownNCT03256981
What this trial is testing

Stereotactic Body Radiotherapy for the Treatment of OPD

Who this might be right for
NSCLC
Institute of Cancer Research, United Kingdom 113
Not applicableLooking for participantsNCT04838899
What this trial is testing

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Who this might be right for
OligoprogressiveCastration-Resistant Prostate Cancer
Sunnybrook Health Sciences Centre 30
Testing effectiveness (Phase 2)Looking for participantsNCT06676722
What this trial is testing

SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy

Who this might be right for
Nasopharyngeal Cancinoma (NPC)SBRTImmunotherapy
The First Affiliated Hospital of Xiamen University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333651
What this trial is testing

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Who this might be right for
Oligometastatic Disease
Li Min 90
Not applicableLooking for participantsNCT06434480
What this trial is testing

SBRT in HCC With Oligoprogression on First-line Immunotherapy

Who this might be right for
HCC
Chinese University of Hong Kong 30
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Next Page